Ausgabe 6/2024
Inhalt (11 Artikel)
Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective
- Open Access
- Current Opinion
Hee Jae Choi, Shilpa Madari, Fenglei Huang
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
- Open Access
- Review Article
Achim Fritsch, Michaela Meyer, Robert O. Blaustein, Maria E. Trujillo, Eunkyung Kauh, Lothar Roessig, Michael Boettcher, Corina Becker
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses
- Open Access
- Systematic Review
Agnieszka Wiesner, Paweł Zagrodzki, Alicja Gawalska, Paweł Paśko
The Effect of Various Degrees of Renal or Hepatic Impairment on the Pharmacokinetic Properties of Once-Weekly Insulin Icodec
- Open Access
- Original Research Article
Hanne Haahr, Blanka Cieslarová, Janne R. Hingst, Shan Jiang, Niels R. Kristensen, Viera Kupčová, Lea Nørgreen, Frank-Dietrich H. Wagner, Stanislav Ignatenko
Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions
- Original Research Article
Yafen Li, Xiaonan Li, Miao Zhu, Huan Liu, Zihan Lei, Xueting Yao, Dongyang Liu
Dose-Response Study of Norepinephrine Infusion for Maternal Hypotension in Preeclamptic Patients Undergoing Cesarean Delivery Under Spinal Anesthesia
- Original Research Article
Yi Chen, Lei Guo, Rui Qin, Nan Xi, Shengfu Wang, Yujie Ma, Xinli Ni
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens
- Open Access
- Original Research Article
Zhiyuan Tan, Swantje Völler, Anyue Yin, Amy Rieborn, A. J. Gelderblom, Tom van der Hulle, Catherijne A. J. Knibbe, Dirk Jan A. R. Moes
Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework
- Open Access
- Original Research Article
Maddalena Centanni, Niels Reijnhout, Abel Thijs, Mats O. Karlsson, Lena E. Friberg
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population
- Original Research Article
Patricia D. Maglalang, Jaydeep Sinha, Kanecia Zimmerman, Sean McCann, Andrea Edginton, Christoph P. Hornik, Chi D. Hornik, William J. Muller, Amira Al-Uzri, Marisa Meyer, Jia-Yuh Chen, Ravinder Anand, Eliana M. Perrin, Daniel Gonzalez, Daniel K. Benjamin Jr, Phyllis Kennel, Cheryl Alderman, Zoe Sund, Kylie Opel, Rose Beci, Chi Dang Hornik, Gregory L. Kearns, Matthew Laughon, Ian M. Paul, Janice Sullivan, Kelly Wade, Paula Delmore, Leanne West, Susan Abdel-Rahman, Elizabeth Payne, Lily Chen, Gina Simone, Kathleen O’Connor, Jennifer Cermak, Lawrence Taylor, Ramany John, William Muller, Ram Yogev, Laura Fearn, Sasidharan Taravath, Tiffony Blanks, Arielle Lapid, Chi Hornik, Melissa Harward, Kira Clark, Sarah Craven, Kimberly Grzesek, Charuta Joshi, Austin Drake, Lauri Filar, Jennifer Sargent, Arpita Lakhotia, Michael Oldham, Julie Burmester, Stephany Eubanks, Terri Simeon, Yael Shiloh-Malawsky, Christopher Anderson, Mallory Jolly, Shradhdha Joshi, Norbert Odero, Jennifer Taylor, Susan Arnold, Caryn Harper, Erica Howard, Maria Martinez, Deanna Myer, Angela Walker, Martha Blackford, Michael Reed, Amanda Hodge, Tasha Capozzi, Heather Anthony, Glenn Stryjewski, Kimberly Klipner, Karen Kowal, Benjamin Traisman, Carol Nielsen, Pam Sroka, Matitiahu Berkovitch, Elkana Kohn, Catherine Litalien, Julie Autmizguine, Diane Desmarasis, Christine Massicotte, Mariana Dumitrascu, Vincent Lague, Neil Goldenberg, Peter Mourani, Jendar Deschenes, Domninic DiDomenico, Megan Dix, Gentle Halstenson, Kathryn Malone, Kimberly Ralston, Alleluiah Rutebemberwa, Yamila Sierra, Matthew Steinbeiss, Kevin Van, Hugh McMillan, Roger Zemek, Thierry Lacaze, Daniela Pohl, Angie Tuttle, Barbara Murchison, Sara Ieradi, Stuart Goldstein, Gary Bradley, Stuart Goldstein, Theresa Mottes, Tara Terrell, Patricia Arnold, Bradley DePaoli, Bradley Gerhardt, Cassie Kirby, Kevin Watt, Grace Jefferson, Nicole Baisden, Heidi Tiedge, Christie Milleson, Samantha Wrenn, Anne Baez, Scott Denne, Brenda Poindexter, Gregory Sokol, Brianne Kost, Ashley Moore, Jaime Deville, Kavita Shankar, Elizabeth Lang, Yaron Finkelstein, Maggie Rumantir, Mobeen Rathore, Kathleen Thoma, Alexandrea Borges, Philip Toltzis, David Speicher, Eloise Lemon, Brenna Vitou, Eileen Goldblatt, Ramon Adams, Catherine Tasi, Lisa Petersen, Ashlee Parsons, Laura James, Dawn Hansberry, Michelle Hart, Lee Howard, D Pierce Ann, Janice Sullivan, Karrie Kernen, Susan Poff, Courtney Konow, Kelli Brown, Jen Comings, Andrew Michael, Jackie Perry, Michelle Wiseheart, Matthew Laughon, Janice Bernhardt, Ashley Mariconti, Jennifer Talbert, Michael Spigarelli, Catherine Sherwin, Fumiko Alger, JoAnn Narus, Rebbecca Perez, Priscilla Rosen, Yakub Salman, Kaylynn Shakespear, Joshua Shimizu, Sharada Dixit, Paula Delmore
P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants
- Original Research Article
Xuening Li, Miwa Haranaka, Hui Li, Pei Liu, Huijun Chen, Stefan Klein, Stefanie Reif, Klaus Francke, Christian Friedrich, Kazuhito Okumura
Comment on: “CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients”
- Letter to the Editor
Thijs H. Oude Munnink, Saskia K. Klein, Daan J. Touw
